RxDoctor Payments Data

William Lackey, MD

Adult Reconstructive Orthopaedic Surgery · Brooklyn, NYNPI 1912014218

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (53.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Arthrex at 43.3% of the total. Reporting peaked in 2019 at $2,627 and has fallen 98.5% since, to $39 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in NY, where the typical reported total is $11,547.

$4,582in general payments, 2019–2025

Across 169 payments — averaging $27.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$2K
  • Amgen$1K
  • Gotham Surgical Solutions & Devices, Inc.$388
  • Endo Pharmaceuticals Inc.$200
  • Smith+Nephew$170
  • Suvon Surgical LLC$148
  • plus $221 from 4 others

What the payments were for

  • Travel & lodging$2054%
  • Food & beverage$2,44953%
  • Education$1,92842%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,582 in reported general payments places this provider in the 25th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$161,394
Medicare patients
257
Services billed
10,476

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen363$5,591
Celecoxib39$4,138
Lidocaine12$1,102
Ibuprofen163$988
Diclofenac Sodium19$581
Oxycodone Hcl66$528
Cyclobenzaprine Hcl68$397
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen44$377
Tramadol Hcl41$325
Naproxen60$307
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine11$282
IbuIbuprofen18$221
Diazepam26$194
Meloxicam84$185
Zolpidem Tartrate ErZolpidem Tartrate15$141

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Brooklyn

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →